Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb).
about
Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary KillingDevelopment and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.High-throughput methods for screening liposome–macrophage cell interaction
P2860
Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Therapeutic aerosol bioenginee ...... obacterium tuberculosis (MTb).
@en
Therapeutic aerosol bioenginee ...... obacterium tuberculosis (MTb).
@nl
type
label
Therapeutic aerosol bioenginee ...... obacterium tuberculosis (MTb).
@en
Therapeutic aerosol bioenginee ...... obacterium tuberculosis (MTb).
@nl
prefLabel
Therapeutic aerosol bioenginee ...... obacterium tuberculosis (MTb).
@en
Therapeutic aerosol bioenginee ...... obacterium tuberculosis (MTb).
@nl
P2093
P2860
P50
P1476
Therapeutic aerosol bioenginee ...... cobacterium tuberculosis (MTb)
@en
P2093
P2860
P2888
P356
10.1007/S10856-011-4511-4
P577
2011-12-20T00:00:00Z